| Similar Articles |
|---|
 |
HBS Working Knowledge
August 27, 2008
Garry Emmons |
Creating Leaders for Science-Based Businesses The unique challenges of managing and leading science-based businesses -- certain to be a driver of this century's new economy -- demand new management paradigms and new educational ones as well   |
Bank Technology News
June 2010
John Pyrovolakis |
Innovators: A Call to Action The Innovation Accelerator wishes to leverage great and innovative technologies developed in our nation's research universities and federal research labs on the strength of federal funding to empower our nation's banking industry. |
HBS Working Knowledge
February 6, 2012
Dina Gerdeman |
Kodak: A Parable of American Competitiveness When American companies move pieces of their operations overseas, they run the risk of moving the expertise, innovation, and new growth opportunities just out of their reach as well. |
CRM
June 24, 2011
Elisa O'Donnell |
Kill the Office of Innovation What it really takes to create a thriving innovation capacity within an organization. |
BusinessWeek
March 6, 2006
Amy Barrett |
Merck: Out Of The Ivory Tower Merck's pragmatic strategy includes tweaking the vitamin niacin to make it a blockbuster. |
HBS Working Knowledge
March 20, 2006
Huston & Sakkab |
P&G's New Innovation Model Procter & Gamble's assessment of its aging innovation process and the development of connect and develop. |
Pharmaceutical Executive
July 1, 2013
Richie Etwaru |
Innovation Calls Across the C-suite: Lessons From Wall Street The lifeblood of the life sciences industry is continuous innovation; it is not a business that can survive by standing still. |
The Motley Fool
December 21, 2006
Brian Lawler |
Dueling Fools: Merck Bull What you are getting with Merck is one of the best-managed pharmas out there that will be experiencing solid double-digit earnings growth in the not-too-distant future with a smart dividend payout. |
HBS Working Knowledge
November 15, 2006
Sean Silverthorne |
Lessons Not Learned About Innovation Professor Rosabeth Moss Kanter discusses her research into the classic traps of innovation -- and how to avoid them. |
Fast Company
April 2008 |
Making Innovation Work Approaching innovation systematically and being ruthless about the allocation of resources to it are keys to a successful business. Here are some simple mistakes made by companies that muffled innovation. |
IndustryWeek
January 31, 2012
Josh Cable |
GE Barometer: Executives Believe Innovation and Growth Go Hand-in-Hand However, uncertainty in the global economy is curbing their companies' appetites for risk and making it harder for them to find capital. |
CIO
August 15, 2001
Sandy kendall |
How Things Change Five top gurus' views on innovation principles and practices... |
The Motley Fool
September 25, 2006
Brian Lawler |
Merck's Positive Contribution Bad press from Vioxx shouldn't overshadow the company's new offering. Investors, take note. |
HBS Working Knowledge
March 1, 2004
Martha Lagace |
Injecting New Life into the Vaccine Industry Vaccines for preventable diseases save millions of lives every year, yet as an industry, the vaccine business suffers a host of ailments, the CEO of Merck & Co. contends. |
HBS Working Knowledge
December 5, 2005
Govindarajan & Trimble |
Not All Innovations Are Equal Innovative strategies alone -- without changes to either the underlying technologies or the products and services sold to customers -- drive the success of many companies. But now, the long-term survival of a company depends on strategic innovation more than ever before. |
IndustryWeek
October 20, 2010 |
Innovation Nation? Manufacturers are more involved than other industries in innovation, but engagement is hardly widespread. |
The Motley Fool
October 23, 2007
Brian Orelli |
Old Merck on New Drugs It looks like the old Merck is back, with new drugs driving double-digit sales growth in the third-quarter. |
Global Services
November 4, 2008
Jolie Newman |
The Innovation Imperative Understand the essential nature of innovation in outsourcing engagements. |
BusinessWeek
June 7, 2004
Port & Tashiro |
Where No Computer Has Gone Before The secrets of fusion energy, subatomic behavior, and more are being attacked by supercomputers capable of supersimulations. |
HBS Working Knowledge
May 30, 2007
Sean Silverthorne |
Health Care Under a Research Microscope The $2 trillion American health care system has grown bloated and overly expensive, and it delivers poor service to many patients. Harvard Business School faculty are looking at the system through a business management perspective to recommend changes. |
Fast Company
March 15, 2007
Tinker Ready |
Not Invented Here The next blockbuster drug could come from anywhere. It's up to Merck's scouts to find it. |
BusinessWeek
July 30, 2007
Arlene Weintraub |
Is Merck's Medicine Working? Spurred by the Vioxx fiasco, CEO Clark is trying to revamp the drug giant's culture. Analysts expect Merck's top line to grow 4%, to $23.5 billion this year, an achievement considering that sales growth had flatlined even before Vioxx imploded. |
BusinessWeek
September 20, 2004
Amy Barrett |
Merck: Who Will Revive The Giant? Earnings and new-drug disappointments have investors worried about succession. |
CIO
November 15, 2005
Michael Schrage |
Innovation Alchemy One of the most important things CIOs can create is the right mix of healthy environment and reliable process in order to foster innovation. |
Inc.
June 2008
Jane Berentson |
Editor's Letter Innovation often begins with a clever entrepreneur who manages not only to conceive a great idea but also to finance it, employ people to improve it, build a company around it - and, eventually, see it to glorious and profitable fruition. |
Bank Systems & Technology
March 29, 2006
Katherine Burger |
You're Wearing That? Innovation is not just about new products and services, but also encompasses business model innovation, process innovation, culture innovation and management system innovation. |
The Motley Fool
November 13, 2007
Brian Orelli |
Merck: Case Closed? Now that Merck has settled its lawsuit, it can get back to business, focusing on continued growth from its cholesterol drugs, new diabetic medication, and cervical cancer vaccine. Investors, take note. |
BusinessWeek
April 15, 2010
James P. Andrew |
What Executives Make of Innovation The head of the global innovation practice at Boston Consulting Group dives more deeply into the findings from this year's survey taken to compile the ranking of the most innovative companies. |
IndustryWeek
June 23, 2010 |
Consider This -- Five Key Concepts for Sustainable Innovation Mastering these fundamentals can stimulate your innovation efforts and the global economy. |
The Motley Fool
March 2, 2005
Brant David McLaughlin |
Merck's Road to Recovery Merck didn't get to where it is by being shortsighted, and management has no plans to start now. Investors would be wise not to take on an excessively negative attitude toward the company in the wake of some dark news. |
The Motley Fool
January 31, 2007
Brian Lawler |
Merck Plays the Waiting Game New acquisitions may help the drugmaker weather tough times. Investors, take note. |
